Skip to main content
Erschienen in: Cancer Causes & Control 3/2013

01.03.2013 | Original paper

Subtype of dietary fat in relation to risk of Hodgkin lymphoma: a population-based case–control study in Connecticut and Massachusetts

verfasst von: Yongshun Gao, Qian Li, Bryan A. Bassig, Ellen T. Chang, Min Dai, Qin Qin, Yawei Zhang, Tongzhang Zheng

Erschienen in: Cancer Causes & Control | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Few epidemiological studies have examined the relationship between dietary fat, which may affect immune function and risk of Hodgkin lymphoma (HL). The aim of this study was to test the hypothesis that high dietary intake of fat and specific subtypes of fat is associated with the risk of HL among 486 HL cases and 630 population-based controls recruited between 1997 and 2000 in Connecticut and Massachusetts. Unconditional logistic regression was used to calculate odds ratios (ORs) and 95 % confidence intervals (CIs) stratified by age and gender. Among younger adults, HL risk was significantly and positively associated with higher intake of saturated fat [ORs for increasing quartiles = 1.3, 1.8, and 2.1; p trend = 0.04] and negatively associated with higher intake of monounsaturated fat [ORs for increasing quartiles = 0.5, 0.5, and 0.4; p trend = 0.03), after adjustment for potential confounders including lifestyle and other dietary factors. The associations with saturated fat (ORs for increasing quartile = 2.4, 3.2, and 4.4; p trend < 0.01] and monounsaturated fat (ORs for increasing quartile = 0.3, 0.6, and 0.3; p trend = 0.04) were most apparent in younger women, whereas there was no significant association between intake of total fat or any type of fat and risk of HL in older females or younger or older males. These findings show that the associations between dietary fat and risk of HL may vary by gender and age and require confirmation in other populations.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kelley DS, Bendich A (1996) Essential nutrients and immunologic functions. Am J Clin Nutr 63:994S–996SPubMed Kelley DS, Bendich A (1996) Essential nutrients and immunologic functions. Am J Clin Nutr 63:994S–996SPubMed
2.
Zurück zum Zitat Cameron RG, Armstrong D, Clandinin MT, Cinader B (1986) Changes in lymphoma development in female SJL/J mice as a function of the ratio in low polyunsaturated/high polyunsaturated fat diet. Cancer Lett 30:175–180PubMedCrossRef Cameron RG, Armstrong D, Clandinin MT, Cinader B (1986) Changes in lymphoma development in female SJL/J mice as a function of the ratio in low polyunsaturated/high polyunsaturated fat diet. Cancer Lett 30:175–180PubMedCrossRef
3.
Zurück zum Zitat Jose DG, Good RA (1973) Quantitative effects of nutritional essential amino acid deficiency upon immune responses to tumors in mice. J Exp Med 137:1–9PubMedCrossRef Jose DG, Good RA (1973) Quantitative effects of nutritional essential amino acid deficiency upon immune responses to tumors in mice. J Exp Med 137:1–9PubMedCrossRef
4.
Zurück zum Zitat Wallace FA, Miles EA, Evans C, Stock TE, Yaqoob P, Calder PC (2001) Dietary fatty acids influence the production of Th1—but not Th2-type cytokines. J Leukoc Biol 69:449–457PubMed Wallace FA, Miles EA, Evans C, Stock TE, Yaqoob P, Calder PC (2001) Dietary fatty acids influence the production of Th1—but not Th2-type cytokines. J Leukoc Biol 69:449–457PubMed
5.
Zurück zum Zitat Skibola CF (2007) Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16:392–395PubMedCrossRef Skibola CF (2007) Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16:392–395PubMedCrossRef
6.
Zurück zum Zitat Kelley DS, Dougherty RM, Branch LB, Taylor PC, Iacono JM (1992) Concentration of dietary N-6 polyunsaturated fatty acids and the human immune status. Clin Immunol Immunopathol 62:240–244PubMedCrossRef Kelley DS, Dougherty RM, Branch LB, Taylor PC, Iacono JM (1992) Concentration of dietary N-6 polyunsaturated fatty acids and the human immune status. Clin Immunol Immunopathol 62:240–244PubMedCrossRef
7.
Zurück zum Zitat Polesel J, Talamini R, Montella M et al (2006) Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case–control study. Ann Oncol 17:713–718PubMedCrossRef Polesel J, Talamini R, Montella M et al (2006) Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case–control study. Ann Oncol 17:713–718PubMedCrossRef
8.
Zurück zum Zitat Zheng T, Holford TR, Leaderer B et al (2004) Diet and nutrient intakes and risk of non-Hodgkin’s lymphoma in Connecticut women. Am J Epidemiol 159:454–466PubMedCrossRef Zheng T, Holford TR, Leaderer B et al (2004) Diet and nutrient intakes and risk of non-Hodgkin’s lymphoma in Connecticut women. Am J Epidemiol 159:454–466PubMedCrossRef
9.
Zurück zum Zitat Purdue MP, Bassani DG, Klar NS, Sloan M, Kreiger N (2004) Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: a case–control analysis. Cancer Epidemiol Biomarkers Prev 13:1665–1676PubMed Purdue MP, Bassani DG, Klar NS, Sloan M, Kreiger N (2004) Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: a case–control analysis. Cancer Epidemiol Biomarkers Prev 13:1665–1676PubMed
10.
Zurück zum Zitat Zhang S, Hunter DJ, Rosner BA et al (1999) Dietary fat and protein in relation to risk of non-Hodgkin’s lymphoma among women. J Natl Cancer Inst 91:1751–1758PubMedCrossRef Zhang S, Hunter DJ, Rosner BA et al (1999) Dietary fat and protein in relation to risk of non-Hodgkin’s lymphoma among women. J Natl Cancer Inst 91:1751–1758PubMedCrossRef
11.
Zurück zum Zitat Chiu BC, Cerhan JR, Folsom AR et al (1996) Diet and risk of non-Hodgkin lymphoma in older women. JAMA 275:1315–1321PubMedCrossRef Chiu BC, Cerhan JR, Folsom AR et al (1996) Diet and risk of non-Hodgkin lymphoma in older women. JAMA 275:1315–1321PubMedCrossRef
12.
Zurück zum Zitat Cross AJ, Ward MH, Schenk M et al (2006) Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case–control study. Carcinogenesis 27:293–297PubMedCrossRef Cross AJ, Ward MH, Schenk M et al (2006) Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case–control study. Carcinogenesis 27:293–297PubMedCrossRef
13.
Zurück zum Zitat Franceschi S, Serraino D, Carbone A, Talamini R, La Vecchia C (1989) Dietary factors and non-Hodgkin’s lymphoma: a case–control study in the northeastern part of Italy. Nutr Cancer 12:333–341PubMedCrossRef Franceschi S, Serraino D, Carbone A, Talamini R, La Vecchia C (1989) Dietary factors and non-Hodgkin’s lymphoma: a case–control study in the northeastern part of Italy. Nutr Cancer 12:333–341PubMedCrossRef
14.
Zurück zum Zitat Tavani A, Pregnolato A, Negri E et al (1997) Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 27:256–260PubMedCrossRef Tavani A, Pregnolato A, Negri E et al (1997) Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 27:256–260PubMedCrossRef
15.
Zurück zum Zitat Chang ET, Zheng T, Lennette ET et al (2004) Heterogeneity of risk factors and antibody profiles in Epstein–Barr virus genome-positive and -negative Hodgkin lymphoma. J Infect Dis 189:2271–2281PubMedCrossRef Chang ET, Zheng T, Lennette ET et al (2004) Heterogeneity of risk factors and antibody profiles in Epstein–Barr virus genome-positive and -negative Hodgkin lymphoma. J Infect Dis 189:2271–2281PubMedCrossRef
16.
Zurück zum Zitat Bohlke K, Harlow BL, Cramer DW, Spiegelman D, Mueller NE (1999) Evaluation of a population roster as a source of population controls: the Massachusetts Resident Lists. Am J Epidemiol 150:354–358PubMedCrossRef Bohlke K, Harlow BL, Cramer DW, Spiegelman D, Mueller NE (1999) Evaluation of a population roster as a source of population controls: the Massachusetts Resident Lists. Am J Epidemiol 150:354–358PubMedCrossRef
17.
Zurück zum Zitat US Census Bureau (2002) 2000 Census of population and housing, summary file 3[Connecticut]. US Census Bureau, Washington, DC US Census Bureau (2002) 2000 Census of population and housing, summary file 3[Connecticut]. US Census Bureau, Washington, DC
18.
Zurück zum Zitat Chang ET, Zheng T, Weir EG et al (2004) Childhood social environment and Hodgkin’s lymphoma: new findings from a population-based case–control study. Cancer Epidemiol Biomarkers Prev 13:1361–1370PubMed Chang ET, Zheng T, Weir EG et al (2004) Childhood social environment and Hodgkin’s lymphoma: new findings from a population-based case–control study. Cancer Epidemiol Biomarkers Prev 13:1361–1370PubMed
19.
Zurück zum Zitat Chang ET, Zheng T, Weir EG et al (2004) Aspirin and the risk of Hodgkin’s lymphoma in a population-based case–control study. J Natl Cancer Inst 96:305–315PubMedCrossRef Chang ET, Zheng T, Weir EG et al (2004) Aspirin and the risk of Hodgkin’s lymphoma in a population-based case–control study. J Natl Cancer Inst 96:305–315PubMedCrossRef
20.
Zurück zum Zitat Morton LM, Turner JJ, Cerhan JR et al (2007) Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110:695–708PubMedCrossRef Morton LM, Turner JJ, Cerhan JR et al (2007) Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110:695–708PubMedCrossRef
21.
Zurück zum Zitat Ambinder RF, Mann RB (1994) Epstein–Barr-encoded RNA in situ hybridization: diagnostic applications. Hum Pathol 25:602–605PubMedCrossRef Ambinder RF, Mann RB (1994) Epstein–Barr-encoded RNA in situ hybridization: diagnostic applications. Hum Pathol 25:602–605PubMedCrossRef
22.
Zurück zum Zitat Gulley ML, Glaser SL, Craig FE et al (2002) Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein–Barr virus in Hodgkin lymphoma. Am J Clin Pathol 117:259–267PubMedCrossRef Gulley ML, Glaser SL, Craig FE et al (2002) Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein–Barr virus in Hodgkin lymphoma. Am J Clin Pathol 117:259–267PubMedCrossRef
23.
Zurück zum Zitat Willett WC, Sampson L, Stampfer MJ et al (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51–65PubMed Willett WC, Sampson L, Stampfer MJ et al (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51–65PubMed
24.
Zurück zum Zitat Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228S discussion 9S–31SPubMed Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228S discussion 9S–31SPubMed
25.
Zurück zum Zitat Greenland S (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79:340–349PubMedCrossRef Greenland S (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79:340–349PubMedCrossRef
26.
Zurück zum Zitat Glaser SL (1986) Recent incidence and secular trends in Hodgkin’s disease and its histologic subtypes. J Chronic Dis 39:789–798PubMedCrossRef Glaser SL (1986) Recent incidence and secular trends in Hodgkin’s disease and its histologic subtypes. J Chronic Dis 39:789–798PubMedCrossRef
27.
Zurück zum Zitat Glaser SL, Swartz WG (1990) Time trends in Hodgkin’s disease incidence. The role of diagnostic accuracy. Cancer 66:2196–2204PubMedCrossRef Glaser SL, Swartz WG (1990) Time trends in Hodgkin’s disease incidence. The role of diagnostic accuracy. Cancer 66:2196–2204PubMedCrossRef
29.
Zurück zum Zitat Howlader NNA, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2012) SEER cancer statistics review, 1975–2009 (Vintage 2009 Populations). National Cancer Institute, Bethesda Howlader NNA, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2012) SEER cancer statistics review, 1975–2009 (Vintage 2009 Populations). National Cancer Institute, Bethesda
30.
Zurück zum Zitat Chen YT, Zheng T, Chou MC, Boyle P, Holford TR (1997) The increase of Hodgkin’s disease incidence among young adults. Experience in Connecticut, 1935–1992. Cancer 79:2209–2218PubMedCrossRef Chen YT, Zheng T, Chou MC, Boyle P, Holford TR (1997) The increase of Hodgkin’s disease incidence among young adults. Experience in Connecticut, 1935–1992. Cancer 79:2209–2218PubMedCrossRef
31.
Zurück zum Zitat Glaser SL, Clarke CA, Stearns CB, Dorfman RF (2001) Age variation in Hodgkin’s disease risk factors in older women: evidence from a population-based case–control study. Leuk Lymphoma 42:997–1004PubMedCrossRef Glaser SL, Clarke CA, Stearns CB, Dorfman RF (2001) Age variation in Hodgkin’s disease risk factors in older women: evidence from a population-based case–control study. Leuk Lymphoma 42:997–1004PubMedCrossRef
32.
Zurück zum Zitat Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF (2002) Social class and risk of Hodgkin’s disease in young–adult women in 1988–94. Int J Cancer 98:110–117PubMedCrossRef Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF (2002) Social class and risk of Hodgkin’s disease in young–adult women in 1988–94. Int J Cancer 98:110–117PubMedCrossRef
33.
Zurück zum Zitat Turner JJ, Morton LM, Linet MS et al (2010) InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood 116:e90–e98PubMedCrossRef Turner JJ, Morton LM, Linet MS et al (2010) InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood 116:e90–e98PubMedCrossRef
34.
Zurück zum Zitat Zurier RB (1993) Fatty acids, inflammation and immune responses. Prostaglandins Leukot Essent Fatty Acids 48:57–62PubMedCrossRef Zurier RB (1993) Fatty acids, inflammation and immune responses. Prostaglandins Leukot Essent Fatty Acids 48:57–62PubMedCrossRef
35.
36.
Zurück zum Zitat Vitale JJ, Broitman SA (1981) Lipids and immune function. Cancer Res 41:3706–3710PubMed Vitale JJ, Broitman SA (1981) Lipids and immune function. Cancer Res 41:3706–3710PubMed
37.
Zurück zum Zitat Cinader B, Clandinin MT, Hosokawa T, Robblee NM (1983) Dietary fat alters the fatty acid composition of lymphocyte membranes and the rate at which suppressor capacity is lost. Immunol Lett 6:331–337PubMedCrossRef Cinader B, Clandinin MT, Hosokawa T, Robblee NM (1983) Dietary fat alters the fatty acid composition of lymphocyte membranes and the rate at which suppressor capacity is lost. Immunol Lett 6:331–337PubMedCrossRef
38.
Zurück zum Zitat Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA (2006) Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 108:3786–3791PubMedCrossRef Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA (2006) Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 108:3786–3791PubMedCrossRef
39.
Zurück zum Zitat Landgren O, Engels EA, Pfeiffer RM et al (2006) Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case–control study in Scandinavia. J Natl Cancer Inst 98:1321–1330PubMedCrossRef Landgren O, Engels EA, Pfeiffer RM et al (2006) Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case–control study in Scandinavia. J Natl Cancer Inst 98:1321–1330PubMedCrossRef
40.
Zurück zum Zitat Vajdic CM, McDonald SP, McCredie MR et al (2006) Cancer incidence before and after kidney transplantation. JAMA 296:2823–2831PubMedCrossRef Vajdic CM, McDonald SP, McCredie MR et al (2006) Cancer incidence before and after kidney transplantation. JAMA 296:2823–2831PubMedCrossRef
41.
Zurück zum Zitat Engels EA, Pfeiffer RM, Fraumeni JF Jr et al (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306:1891–1901PubMedCrossRef Engels EA, Pfeiffer RM, Fraumeni JF Jr et al (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306:1891–1901PubMedCrossRef
42.
Zurück zum Zitat Pollak M (2000) Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36:1224–1228PubMedCrossRef Pollak M (2000) Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36:1224–1228PubMedCrossRef
43.
Zurück zum Zitat Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574PubMedCrossRef Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574PubMedCrossRef
44.
Zurück zum Zitat Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215–244PubMedCrossRef Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215–244PubMedCrossRef
45.
Zurück zum Zitat Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34PubMed Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34PubMed
Metadaten
Titel
Subtype of dietary fat in relation to risk of Hodgkin lymphoma: a population-based case–control study in Connecticut and Massachusetts
verfasst von
Yongshun Gao
Qian Li
Bryan A. Bassig
Ellen T. Chang
Min Dai
Qin Qin
Yawei Zhang
Tongzhang Zheng
Publikationsdatum
01.03.2013
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 3/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0136-2

Weitere Artikel der Ausgabe 3/2013

Cancer Causes & Control 3/2013 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.